Serum level of HER-2/neu in patients with gastric cancer: Correlation withHER-2/neu overexpression in gastric carcinoma tissue

Citation
K. Kono et al., Serum level of HER-2/neu in patients with gastric cancer: Correlation withHER-2/neu overexpression in gastric carcinoma tissue, TUMOR BIOL, 21(3), 2000, pp. 139-144
Citations number
26
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
TUMOR BIOLOGY
ISSN journal
10104283 → ACNP
Volume
21
Issue
3
Year of publication
2000
Pages
139 - 144
Database
ISI
SICI code
1010-4283(200005/06)21:3<139:SLOHIP>2.0.ZU;2-E
Abstract
Serum HER-2/neu (c-erbB-2) levels in patients with gastric cancer were eval uated by an enzyme-linked immunosorbent assay and tissue levels of HER-2/ne u in the same cohort were determined by immunohistochemistry. Nine (16%) of 57 gastric carcinomas had an overexpression of HER-2/neu detected immunohi stochemically. Of these 9 patients, 6 had elevated serum HER-2/neu levels, while 45 of 48 tissue samples with negative staining exhibited normal serum HER-2/neu levels. These results indicated that overall accuracy, positive predictive value, and negative predictive values of their serum measurement s were 89, 67 and 94%, respectively. Serum levels of HER-2/neu were correla ted with tissue overexpression of HER-2/neu in patients with gastric cancer . Copyright (C) 2000 S. Karger AG, Basel.